Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020

替加环素 鲍曼不动杆菌 肉汤微量稀释 粘菌素 美罗培南 抗菌剂 抗药性 头孢菌素 微生物学 抗生素 医学 抗生素耐药性 生物 最小抑制浓度 细菌 铜绿假单胞菌 遗传学
作者
Chih-Hao Chen,Pin-Han Wu,Min‐Chi Lu,Mao‐Wang Ho,Po‐Ren Hsueh
出处
期刊:International Journal of Antimicrobial Agents [Elsevier BV]
卷期号:61 (2): 106707-106707 被引量:18
标识
DOI:10.1016/j.ijantimicag.2022.106707
摘要

This study evaluated the in-vitro activity of multiple classes of antibiotics, including novel β-lactam combination agents, tigecycline and colistin, against carbapenem-resistant (CRAB), multi-drug-resistant (MDRAB) and difficult-to-treat (DTRAB) Acinetobacter baumannii. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution method. Susceptibility profiles and the distribution of selected antimicrobials among countries were illustrated and examined based on the breakpoints of the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing and the US Food and Drug Administration. In total, 847 A. baumannii isolates were evaluated, and 692 isolates were characterized as CRAB, MDRAB or DTRAB. The prevalence of drug-resistant A. baumannii was >70.0% in South Korea, India and China, while the resistance rate of tigecycline was <5.5%. The MICs of meropenem and meropenem/vaborbactam for drug-resistant A. baumannii were equal (both MIC50 and MIC90 were 32 mg/L, range 0.25-32 mg/L). The overall resistance rate remained high for multiple classes of antibiotics, including penicillins, cephalosporins, carbapenems, quinolones and aminoglycosides (>84.0%, >96.0%, >98.0%, >88.0% and >87.0%, respectively), but not colistin or tigecycline (1.1% and 4.3%, respectively). China showed the lowest susceptibility to tigecycline for drug-resistant A. baumannii isolates compared with other countries. In conclusion, the resistance rate of drug-resistant A. baumannii remains high against multiple classes of antimicrobials. Colistin was the most potent agent, followed by tigecycline. The geographic pattern of tigecycline-resistant A. baumannii varied among countries. Therefore, continuous surveillance of A. baumannii resistance profiles in different regions is required.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
heew发布了新的文献求助10
1秒前
1秒前
王子睿发布了新的文献求助10
2秒前
乐乐应助小潘采纳,获得10
2秒前
NexusExplorer应助糟糕的黎云采纳,获得10
2秒前
2秒前
4秒前
5秒前
manfullmoon发布了新的文献求助30
7秒前
7秒前
heew完成签到,获得积分10
8秒前
8秒前
10秒前
10秒前
zhangxinxin发布了新的文献求助10
11秒前
行万里发布了新的文献求助10
13秒前
六六完成签到,获得积分10
14秒前
搜集达人应助王进采纳,获得10
15秒前
天天发布了新的文献求助10
15秒前
Belikov应助自由月亮采纳,获得30
15秒前
超级幻梅发布了新的文献求助10
16秒前
传奇3应助BW采纳,获得10
16秒前
Yancy发布了新的文献求助10
18秒前
辛勤冬天发布了新的文献求助30
18秒前
神火发布了新的文献求助10
19秒前
科目三应助阔达的梨愁采纳,获得10
21秒前
23秒前
anan完成签到 ,获得积分10
25秒前
芜湖发布了新的文献求助10
26秒前
31秒前
朱佳宁完成签到 ,获得积分10
32秒前
科研小秦完成签到,获得积分10
32秒前
Hello应助超级幻梅采纳,获得10
33秒前
借过123发布了新的文献求助10
35秒前
打打应助王进采纳,获得10
35秒前
立冬完成签到,获得积分10
37秒前
CC发布了新的文献求助10
39秒前
39秒前
Jie完成签到,获得积分10
42秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Malcolm Fraser : a biography 700
Handbook of Optical Systems,Volume 6:Advanced Physical Optics 666
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6514425
求助须知:如何正确求助?哪些是违规求助? 8307857
关于积分的说明 17753401
捐赠科研通 5616319
什么是DOI,文献DOI怎么找? 2924666
邀请新用户注册赠送积分活动 1901600
关于科研通互助平台的介绍 1763068